PedAM
Pediatric Disease Annotations & Medicines
| Disease | atrial fibrillation |
| Phenotype | C0034065|pulmonary embolism |
| Sentences | 3 |
| PubMedID- 22212132 | Is atrial fibrillation associated with pulmonary embolism. |
| PubMedID- 23365716 | Rivaroxaban has successfully met primary efficacy and safety endpoints in large, randomized phase iii trials across several indications, including: prevention of venous thromboembolism in orthopedic patients undergoing elective hip or knee replacement surgery; treatment of deep vein thrombosis and secondary prevention of deep vein thrombosis and pulmonary embolism; stroke prevention in patients with atrial fibrillation; and secondary prevention of acute coronary syndrome. |
| PubMedID- 24019755 | Such patientsinclude those with thrombophilias, prosthetic heart valves, presence of deep venous thrombosis orpulmonary embolism, and in patients with atrial fibrillation at risk for thromboembolism.1,2 alarge subset of patients taking this medication are those with atrial fibrillation and currentprojections show that in 2020 more than 7.5 million people in the united states will be diagnosedwith atrial fibrillation. |
Page: 1